AFFiRiS AG Alternatives & Competitors
12 companies similar to AFFiRiS AG — Novel disease-modifying therapies for neurodegenerative diseases. From brains fo...
Companies similar to AFFiRiS AG
AC Immune
Shifting the treatment paradigm for neurodegenerative disease towards precision medicine a...
Lausanne, Switzerland
Athira Pharma
Restoring lives by advancing bold therapies for neuronal health, thoughtfully and urgently
Bothell, United States
Vaxxinity
Our mission is to democratize health by pioneering the third biologic revolution
United States
Cognition Therapeutics, Inc.
Advancing Accessible Solutions for Complex Neurodegenerative Diseases
United States
Rival Readout
Competing with AFFiRiS AG? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Alector
We are on a mission to make brain disorders history.
South San Francisco, Unit...
Upstream Bio
Developing treatments for inflammatory diseases
Waltham, United States
KeifeRx
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...
Mclean, United States
Cantabio Pharmaceuticals, Inc.
Cantabio aim to slow, stop and even prevent the onset & progression of neurodegenerative d...
Sunnyvale, United States
Vertero Therapeutics, Inc.
Pioneering science beyond the brain to treat neurodegenerative diseases at their source
Woburn, United States
ALSP, Inc.
Pioneering small molecule therapies for neurodegenerative diseases, focusing on innovative...
La Jolla, United States
Prilenia
Dedicated to developing new treatments for neurodegenerative diseases and neurodevelopment...
Boston, United States
Resverlogix Corp.
Research-driven biotechnology company developing epigenetic therapies for the treatment of...
Calgary, Canada
About AFFiRiS AG
AFFiRiS AG is a clinical-stage biotechnology company based in Austria, founded in 2003. The company's slogan, "Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains.
Immunotherapy, Neurodegenerative Diseases, Parkinson's Disease, Alzheimer's Disease, Multiple System Atrophy, Dementia With Lewy Bodies, Huntington's Disease, Clinical-stage Biotechnology, SAIT, AFFITOME Technology, Peptide Vaccines, Vienna, Austria, Clinical Trials, Monoclonal Antibody
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around AFFiRiS AG: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at AFFiRiS AG on 28 May 2026. The 11 companies listed here were last checked between 11 Sep 2024 and 16 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
